NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 672055 | Null | 0.0112425217758229 | 0.41690434 |
NSC 679021 | Null | 0.0112425217758229 | 0.40713026 |
NSC 683564 | 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- | 0.0112425217758229 | 0.49307893 |
NSC 686553 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- | 0.0112425217758229 | 0.39365961 |
NSC 688526 | Null | 0.0112425217758229 | -0.23729327 |
NSC 697715 | Null | 0.0112425217758229 | -0.27213446 |
NSC 723906 | 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline | 0.0112425217758229 | 0.38489102 |
NSC 724784 | (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 | 0.0112425217758229 | 0.43848113 |
NSC 731527 | cyanoaminopyranopyridine derivatives | 0.0112425217758229 | -0.23267779 |
NSC 756140 | GSK1220512A | 0.0112425217758229 | 0.22758413 |